Paper6574828
A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
Bolanowska W and 2 others. Cancer Chemother Pharmacol, 1983. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography. Papers, record 6574828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6574828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromatography, High Pressure Liquid | Major topic |
| Daunorubicin | Major topic |
| Doxorubicin | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Humans |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-13038 | NCI NIH HHS | United States | P01CA013038 | PubMed and NIH | NIH RePORTER |
| CA-21071 | NCI NIH HHS | United States | P01CA021071 | PubMed and NIH | NIH RePORTER |
| CA-24538 | NCI NIH HHS | United States | P30CA024538 | PubMed and NIH | NIH RePORTER |
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 942583 | Clinical effects and pharmacokinetics of different dosage schedules of adriamycin. | Cancer Res | 1976 | https://conductscience.org/library/papers/942583 | PubMed |
| 2 | 541422 | Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. | J Chromatogr | 1979 | https://conductscience.org/library/papers/541422 | PubMed |
| 3 | 6104578 | Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography. | Drug Metab Dispos | 1980 | https://conductscience.org/library/papers/6104578 | PubMed |
| 4 | 5527015 | Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods. | Cancer Chemother Rep | 1970 | https://conductscience.org/library/papers/5527015 | PubMed |
| 5 | 4723268 | Pharmacokinetics and metabolism of adriamycin in man. | Clin Pharmacol Ther | 1973 | https://conductscience.org/library/papers/4723268 | PubMed |
| 6 | 659557 | Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients. | J Chromatogr | 1978 | https://conductscience.org/library/papers/659557 | PubMed |
| 7 | 835599 | Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. | Am J Med | 1977 | https://conductscience.org/library/papers/835599 | PubMed |
| 8 | 4512953 | Daunorubicin in the therapy of acute granulocytic leukemia. | Cancer Res | 1973 | https://conductscience.org/library/papers/4512953 | PubMed |
| 9 | 795537 | Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. | Cancer Treat Rep | 1976 | https://conductscience.org/library/papers/795537 | PubMed |
| 10 | 6459335 | Rapid high-performance liquid chromatographic assay for the anthracyclines daunorubicin and 7-con-O-methylnogarol in plasma. | J Chromatogr | 1981 | https://conductscience.org/library/papers/6459335 | PubMed |
| 11 | 541423 | Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. | J Chromatogr | 1979 | https://conductscience.org/library/papers/541423 | PubMed |
| 12 | 4290058 | Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. | Cancer | 1967 | https://conductscience.org/library/papers/4290058 | PubMed |
| 13 | 548536 | Quantitative thin-layer chromatography: thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue. | J Chromatogr | 1979 | https://conductscience.org/library/papers/548536 | PubMed |
| 14 | 649731 | Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol. | J Chromatogr | 1978 | https://conductscience.org/library/papers/649731 | PubMed |
| 15 | 6930988 | Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia. | Cancer Lett | 1980 | https://conductscience.org/library/papers/6930988 | PubMed |
| 16 | 856462 | Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. | Cancer Res | 1977 | https://conductscience.org/library/papers/856462 | PubMed |
| 17 | 6927044 | Simplified toxicologic monitoring of adriamycin, its major metabolites and nogalamycin by reverse-phase high pressure liquid chromatography, Part I: Analytical techniques for isolated human plasma. | J Anal Toxicol | 1980 | https://conductscience.org/library/papers/6927044 | PubMed |
| 18 | 1107570 | Adriamycin-a review. | J Natl Cancer Inst | 1975 | https://conductscience.org/library/papers/1107570 | PubMed |
| 19 | 7090422 | Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice. | Xenobiotica | 1982 | https://conductscience.org/library/papers/7090422 | PubMed |
| 20 | 4277990 | Adriamycin cardiotoxicity in man. | Ann Intern Med | 1974 | https://conductscience.org/library/papers/4277990 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33195033 | A DNA Based Biosensor Amplified With ZIF-8/Ionic Liquid Composite for Determination of Mitoxantrone Anticancer Drug: An Experimental/Docking Investigation. | Front Chem | 2020 | https://conductscience.org/library/papers/33195033 | PubMed |
| 6697426 | Relationship between plasma adriamycin levels and the outcome of remission induction therapy for acute nonlymphocytic leukemia. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6697426 | PubMed |
| 3600054 | Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy. | Med Oncol Tumor Pharmacother | 1987 | https://conductscience.org/library/papers/3600054 | PubMed |
| 3520474 | Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties. | Pharm Weekbl Sci | 1986 | https://conductscience.org/library/papers/3520474 | PubMed |
| 3106964 | Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3106964 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6574828
GET https://conductscience.org/api/papers/v1/6574828/references?page=2